Skip to search
Skip to main content
Catalog
Help
Feedback
Your Account
Library Account
Bookmarks
(
0
)
Search History
Search in
Keyword
Title (keyword)
Author (keyword)
Subject (keyword)
Title starts with
Subject (browse)
Author (browse)
Author (sorted by title)
Call number (browse)
search for
Search
Advanced Search
Bookmarks
(
0
)
Princeton University Library Catalog
Start over
Cite
Send
to
SMS
Email
EndNote
RefWorks
RIS
Printer
Bookmark
VA health care, improvements needed to the monitoring of antidepressant use for major depressive disorder and the accuracy of suicide data : testimony before the Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives / statement of Randall B. Williamson.
Author
United States. Government Accountability Office
[Browse]
Format
Book
Language
English
Published/Created
[Washington, D.C.] : United States Government Accountability Office, 2015.
Description
1 online resource (13 pages) : color illustrations.
Availability
Available Online
Marcive GPO Government Documents
Details
Subject(s)
United States Department of Veterans Affairs
—
Rules and practice
[Browse]
Suicide
—
United States
—
Prevention
[Browse]
Veterans
—
Mental health
—
United States
[Browse]
Author
Williamson, Randall B.
[Browse]
Sponsoring body
United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Oversight and Investigations
[Browse]
Series
Testimony ; GAO-15-648 T.
[More in this series]
Testimony ; GAO-15-648T
[More in this series]
Summary note
"In 2013, VA estimated that about 1.5 million veterans required mental health care, including for MDD. MDD is a debilitating mental illness related to reduced quality of life and increased risk for suicide. VA also plays a role in suicide risk assessment and prevention. This testimony addresses the extent to which (1) veterans with MDD who are prescribed an antidepressant receive recommended care and (2) VAMCs are collecting information on veteran suicides as required by VA. The testimony is based on GAO's November 2014 report, VA Health Care: Improvements Needed in Monitoring Antidepressant Use for Major Depressive Disorder and in Increasing Accuracy of Suicide Data (GAO-15-55). For that report GAO analyzed VA data, interviewed VA officials, and conducted site visits to six VAMCs selected based on geography and population served. GAO also reviewed randomly selected medical records for five veterans from each of the six VAMCs, for veterans diagnosed with MDD and prescribed an antidepressant in 2012, as well as all completed BHAP templates. The results cannot be generalized across VA. GAO followed up in May 2015 to determine the status of GAO's previous recommendations"--Preliminary page.
Notes
"For release ... June 10, 2015."
Bibliographic references
Includes bibliographical references.
Source of description
Online resource, PDF version; title from caption (GAO web site, November 25, 2016).
Contents
Background
Veterans in our review often did not receive recommended care, and VA lacks methods to track whether recommended care is provided
Data VA collects on veteran suicides were not always complete, accurate, or consistent.
Other title(s)
Improvements needed to the monitoring of antidepressant use for major depressive disorder and the accuracy of suicide data
Veterans Affairs health care, improvements needed to the monitoring of antidepressant use for major depressive disorder and the accuracy of suicide data
SuDoc no.
GA 1.5/2:GAO-15-648 T
Tech. report no.
GAO-15-648T
Statement on language in description
Princeton University Library aims to describe library materials in a manner that is respectful to the individuals and communities who create, use, and are represented in the collections we manage.
Read more...
Other views
Staff view
Ask a Question
Suggest a Correction
Report Harmful Language
Supplementary Information